Prostate Cancer Trial, Recruiting (NCT06672926)

Prostate Cancer Trial, Recruiting NCT06672926 Sponsor: University Hospitals of North Midlands NHS Trust Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06672926 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

MRI radiographers (medical imaging specialists) who work at University Hospitals of North Midlands (UHNM) or University Hospitals of Derby and Burton (UHDB) and have more than 5 years of experience performing MRI scans of the prostate.
Radiographers from UHNM or UHDB who have completed both the online and hands-on training materials specifically required for this study before the testing phase begins.
Past patient records may also be included — specifically, retrospective (historical) scan and biopsy data from 800 patients at each hospital who previously had a type of prostate MRI scan called mpMRI and then went on to have a biopsy.

Who may not be able to join:

Radiographers who do not specialise in MRI scanning.
Radiographers who have not completed both the online and hands-on study-specific training before the testing phase.
Patient records from scans that were not mpMRI (a specific type of prostate MRI) would not be eligible for inclusion.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01782 675380

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06672926

Sponsor: University Hospitals of North Midlands NHS Trust

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 01782 675380

More information: https://clinicaltrials.gov/study/NCT06672926

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

MRI radiographers (medical imaging specialists) who work at University Hospitals of North Midlands (UHNM) or University Hospitals of Derby and Burton (UHDB) and have more than 5 years of experience performing MRI scans of the prostate.
Radiographers from UHNM or UHDB who have completed both the online and hands-on training materials specifically required for this study before the testing phase begins.
Past patient records may also be included — specifically, retrospective (historical) scan and biopsy data from 800 patients at each hospital who previously had a type of prostate MRI scan called mpMRI and then went on to have a biopsy.

Who may not be able to join:

Radiographers who do not specialise in MRI scanning.
Radiographers who have not completed both the online and hands-on study-specific training before the testing phase.
Patient records from scans that were not mpMRI (a specific type of prostate MRI) would not be eligible for inclusion.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospitals of North Midlands NHS Trust

Registry

ClinicalTrials.gov

Start date

23 September 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Use of Gadolinium Based Contrast Agent (GBCA) injection; Application of WB-MRI; Radiographers opinions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov